The Business Research Company's Igalmi (Dexmedetomidine) Sublingual film to Transform Acute Agitation & Aggression Treatment Market in 2025 LONDON, GREATER LONDON, UNITED KINGDOM, January 31, 2025 ...

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...

Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 12.79%, which has investors questioning if this is right ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...

A cyclical trend of interest in the ability to shoot spit from your salivary glands has TikTokers once again asking, “What is ...

NICE has endorsed a new daily tablet treatment, Acarizax, designed to alleviate symptoms and enhance the quality of life for ...

The following is a summary of “Evaluating the use of Uromune® autovaccine in recurrent urinary tract infections: a pilot unicenter retrospective study in Reus, Spain,” published in the January 2025 ...

People are horrified to learn about gleeking, a disgusting human function which enables people to spit saliva in a certain ...